Trial Profile
Allogeneic stem cell transplantation for children and Adolescents with CML: Conditioning regimen, donor selection, supportive care and diagnostic procedures
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary) ; Melphalan (Primary) ; Thiotepa (Primary) ; Antithymocyte globulin; Ciclosporin; Ciclosporin; Mycophenolate mofetil
- Indications Chronic myeloid leukaemia; Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms CML-SCT-IBFM
- 14 Apr 2021 Status changed from active, no longer recruiting to completed.
- 05 Feb 2021 This trial has been completed in Czech Republic, according to European Clinical Trials Database record. (Global end date:2020-12-01)
- 18 Dec 2020 This trial is Discontinued in Austria (Global End Date: 01 Dec 2020), according to European Clinical Trials Database record.